Rescue of coagulation factor VII function by the U1 + 5A snRNAPINOTTI, Mirko; BALESTRA, Dario; RIZZOTTO, Lara et al.Blood. 2009, Vol 113, Num 25, pp 6461-6464, issn 0006-4971, 4 p.Article

Efficacy of recombinant activated Factor VII in patients with massive uncontrolled bleeding : a retrospective observational analysisBERKHOFAND, Farida F; EIKENBOOM, Jeroen C. J.Transfusion (Philadelphia, PA). 2009, Vol 49, Num 3, pp 570-577, issn 0041-1132, 8 p.Article

Recombinant activated factor VII and the anaesthetistWELSBY, I. J; MONROE, D. M; LAWSON, J. H et al.Anaesthesia. 2005, Vol 60, Num 12, pp 1203-1212, issn 0003-2409, 10 p.Article

Déficit congénital en facteur VII : à propos d'une observation = The constitutional deficiency in factor VII : about one caseIMANE, Z; MDAGHRI-ALAOUI, A; HAMDANI, S et al.Journal de pédiatrie et de puériculture. 2004, Vol 17, Num 3, pp 139-142, issn 0987-7983, 4 p.Article

Ul-snRNA-mediated rescue of mRNA processing in severe factor VII deficiencyPINOTTI, Mirko; RIZZOTTO, Lara; BALESTRA, Dario et al.Blood. 2008, Vol 111, Num 5, pp 2681-2684, issn 0006-4971, 4 p.Article

A method for the determination of activated factor VII using bovine and rabbit brain thromboplastins: demonstration of increased levels in disseminated intravascular coagulationKITCHEN, S; MALIA, R. G; GREAVES, M et al.Thrombosis research. 1988, Vol 50, Num 1, pp 191-200, issn 0049-3848Article

Evaluation of the nature of mildly prolonged prothrombin timesMAZZUCCONI, M. G; MARIANI, G; CHISTOLINI, A et al.American journal of hematology. 1987, Vol 24, Num 1, pp 37-45, issn 0361-8609Article

Plasma concentration of tissue factor and factor VII in patients after abdominal surgeryALBRECHT, S; MÜLLER, S; SIEGERT, G et al.Thrombosis research. 1995, Vol 77, Num 6, pp 557-562, issn 0049-3848Article

The role of phospholipids and the factor VII gla-domain in the interaction of factor VII with tissue factorWILDGOOSE, P; JØRGENSEN, T; KOMIYAMA, Y et al.Thrombosis and haemostasis. 1992, Vol 67, Num 6, pp 679-685, issn 0340-6245Article

Steps towards an effective treatment strategy in congenital factor VII deficiencyMARIANI, Guglielmo; LAPECORELLA, Mario; DOLCE, Alberto et al.Seminars in hematology. 2006, Vol 43, Num 1, pp S42-S47, issn 0037-1963, SUP1Conference Paper

Purification and characterization of factor VII 304-Gln : a variant molecule with reduced activity isolated from a clinically unaffected maleO'BRIEN, D. P; GALE, K. M; SIMON ANDERSON, J et al.Blood. 1991, Vol 78, Num 1, pp 132-140, issn 0006-4971Article

Generation of a humanized, high affinity anti-tissue factor antibody for use as a novel antithrombotic therapeuticPRESTA, Leonard; SIMS, Paul; IVERSON, Mark et al.Thrombosis and haemostasis. 2001, Vol 85, Num 3, pp 379-389, issn 0340-6245Article

Médicaments dérivés du plasma et hémostase : actualités, perspectivesSTV. Sang thrombose vaisseaux. 2001, Vol 13, Num MAR, issn 0999-7385, 103 p., NSConference Proceedings

Plasma phospholipid fatty acid composition and factor VII coagulant activityFOLSOM, A. R; JING MA; ECKFELDT, J. H et al.Atherosclerosis. 1994, Vol 111, Num 2, pp 199-207, issn 0021-9150Article

Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulationO'HARA, P. J; GRANT, F. J; HALDEMAN, B. A et al.Proceedings of the National Academy of Sciences of the United States of America. 1987, Vol 84, Num 15, pp 5158-5162, issn 0027-8424Article

The Use of Tissue Thromboplastins of Different Origin Is a Fundamental Tool in the Initial Characterization of FVII Defects On Factor VII Deficiency (Semin Thromb Hemost 2009;35(4):400-406)GIROLAMI, Antonio; SCANDELLARI, Raffaella; LOMBARDI, A. M et al.Seminars in thrombosis and hemostasis. 2010, Vol 36, Num 1, pp 123-124, issn 0094-6176, 2 p.Article

The importance of tissue factor source in the management of Factor VII deficiencyBOLTON-MAGGS, Paula H. B; HAY, Charles R. M; SHANKS, Doreen et al.Thrombosis and haemostasis. 2007, Vol 97, Num 1, pp 151-152, issn 0340-6245, 2 p.Article

Levels of plasma factor VII and factor VII activated forms as a function of plasma triglyceride levelsNEGRI, M; ARIGLIANO, P. L; TALAMINI, G et al.Atherosclerosis. 1993, Vol 99, Num 1, pp 55-61, issn 0021-9150Article

Failure of recombinant activated factor VII during surgery in a hepophiliac with high-titer factor VIII antibodyGRINGERI, A; SANTAGOSTINO, E; MANNUCCI, P. M et al.Haemostasis. 1991, Vol 21, Num 1, pp 1-4, issn 0301-0147Article

Arthropathy and surgery in congenital factor VII deficiencyKUZEL, T; GREEN, D; STULBERG, S. D et al.The American journal of medicine. 1988, Vol 84, pp 771-774, issn 0002-9343Article

Application of factor VII-sepharose affinity chromatography in the purification of human tissue factor apoproteinBOM, V. J. J; RAM, I. E; ALDERKAMP, G. H. J et al.Thrombosis research. 1986, Vol 42, Num 5, pp 635-643, issn 0049-3848Article

The increase with age of the components of the tissue factor coagulation pathway is gender-dependentARIËNS, R. A. S; COPPOLA, R; POTENZA, I et al.Blood coagulation & fibrinolysis. 1995, Vol 6, Num 5, pp 433-437, issn 0957-5235Article

Aprotinin is a competitive inhibitor of the factor VIIa-tissue factor complexCHABBAT, J; PORTE, P; TELLIER, M et al.Thrombosis research. 1993, Vol 71, Num 3, pp 205-215, issn 0049-3848Article

Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIaVIJAYA MOHAN RAO, L; RAPAPORT, S. I; HOANG, A. D et al.Blood. 1993, Vol 81, Num 10, pp 2600-2607, issn 0006-4971Article

Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a Phase I studyMACIK, B. G; LINDLEY, C. M; LUSHER, J et al.Blood coagulation & fibrinolysis. 1993, Vol 4, Num 4, pp 521-527, issn 0957-5235Article